Dentsply Sirona to review Q2 2026 results on August 6

0 min read | Published on 22 Jul 2026, 04:49 AM |Updated on 22 Jul 2026, 04:49 AM

Reviewed by

Suketu GScanX News Team

Key Highlights

Dentsply Sirona announced it will host an investor conference call and live webcast on August 6, 2026, to review its second quarter 2026 financial results. The call is scheduled for 4:30 p.m. ET, with financial earnings materials to be released beforehand on the company's investor website.

*this image is generated using AI for illustrative purposes only.

Dentsply Sirona will review its second quarter 2026 financial results during an investor conference call and live webcast scheduled for August 6, 2026, at 4:30 p.m. ET. The announcement provides stakeholders with an opportunity to assess the company's performance for the quarter.

Financial earnings materials will be accessible on the Investors section of the Dentsply Sirona website prior to the call. Participants planning to join the conference call must register through the provided link on the company's investor relations portal. A replay of the webcast will be available on the website following the event.

Conference Call Details

Event	Date	Time	Access
Conference Call	August 6, 2026	4:30 p.m. ET	Investor website registration
Webcast Replay	Post-call	Available online	Investor website

Dentsply Sirona is headquartered in Charlotte, North Carolina, and its shares are listed on Nasdaq under the symbol XRAY. The company operates as a diversified manufacturer of professional dental products and technologies.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What strategic initiatives will Dentsply Sirona prioritize to drive growth in the second half of 2026?

How might the Q2 2026 results influence investor sentiment regarding the company's competitive position in the dental technology market?

What potential macroeconomic or industry-specific factors could impact Dentsply Sirona's performance in the upcoming quarters?

BMO Capital initiates coverage on Dentsply Sirona with Market Perform rating

0 min read | Published on 09 Jul 2026, 09:54 PM |Updated on 09 Jul 2026, 09:54 PM

Reviewed by

Radhika SScanX News Team

Add as a preferred
source on Google

Key Highlights

BMO Capital has initiated coverage on Dentsply Sirona with a Market Perform rating and announced a price target of $12, indicating a neutral outlook.

*this image is generated using AI for illustrative purposes only.

BMO Capital has initiated coverage on Dentsply Sirona with a Market Perform rating and announced a price target of $12. The rating provides a neutral outlook on the stock's performance relative to the broader market.

Coverage Details

The initiation of coverage follows a review of Dentsply Sirona's current market position and future prospects. BMO Capital's assessment resulted in the assignment of a Market Perform rating, indicating an expectation for the stock to perform in line with the market average.

Metric	Value
Rating	Market Perform
Price Target	$12

The price target of $12 serves as a benchmark for the stock's valuation over the specified coverage period. Investors will monitor the stock's performance against this target.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific factors could drive Dentsply Sirona's stock to outperform the Market Perform rating?

How might recent industry trends impact Dentsply Sirona's ability to meet the $12 price target?

What are the key risks BMO Capital identified that could hinder the stock's performance?